Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Malignant Melanoma

  Free Subscription


1 Am J Dermatopathol
1 Ann Surg Oncol
2 BMC Cancer
1 Cancer
1 Clin Cancer Res
1 Int J Cancer
3 J Am Acad Dermatol
3 J Cell Physiol
1 J Invest Dermatol
3 Melanoma Res
1 Nat Med
1 Oncol Rep
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Dermatopathol

  1. ALKHASAWNEH A, Nassri A, John I
    Dedifferentiated Melanoma With Expression of Cytokeratin and GATA3 in a Patient With History of Breast Carcinoma.
    Am J Dermatopathol. 2018 Dec 7. doi: 10.1097/DAD.0000000000001322.
    PubMed     Text format     Abstract available

    Ann Surg Oncol

  2. CHAKERA AH, Quinn MJ, Lo S, Drummond M, et al
    Subungual Melanoma of the Hand.
    Ann Surg Oncol. 2018 Dec 18. pii: 10.1245/s10434-018-07094.
    PubMed     Text format     Abstract available

    BMC Cancer

  3. ROSE AM, Luo R, Radia UK, Kalirai H, et al
    Detection of mutations in SF3B1, EIF1AX and GNAQ in primary orbital melanoma by candidate gene analysis.
    BMC Cancer. 2018;18:1262.
    PubMed     Text format     Abstract available

  4. MCQUADE JL, Homsi J, Torres-Cabala CA, Bassett R, et al
    A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma.
    BMC Cancer. 2018;18:1274.
    PubMed     Text format     Abstract available


  5. APPENZELLER S, Gesierich A, Thiem A, Hufnagel A, et al
    The identification of patient-specific mutations reveals dual pathway activation in most patients with melanoma and activated receptor tyrosine kinases in BRAF/NRAS wild-type melanomas.
    Cancer. 2018 Dec 18. doi: 10.1002/cncr.31843.
    PubMed     Text format     Abstract available

    Clin Cancer Res

  6. VAN MEIR EG, Dong L, You S, Zhang Q, et al
    Arylsulfonamide 64B inhibits hypoxia/HIF-induced expression of c-Met and CXCR4 and reduces primary tumor growth and metastasis of uveal melanoma.
    Clin Cancer Res. 2018 Dec 18. pii: 1078-0432.CCR-18-1368.
    PubMed     Text format     Abstract available

    Int J Cancer

  7. GUO D, Lui GYL, Lai SL, Wilmott JS, et al
    RAB27A promotes melanoma cell invasion and metastasis via regulation of pro-invasive exosomes.
    Int J Cancer. 2018 Dec 17. doi: 10.1002/ijc.32064.
    PubMed     Text format     Abstract available

    J Am Acad Dermatol

  8. GARDNER LJ, Strunck JL, Wu YP, Grossman D, et al
    Current controversies in early-stage melanoma: Questions on incidence, screening, and histologic regression.
    J Am Acad Dermatol. 2019;80:1-12.
    PubMed     Text format     Abstract available

    Commentary: Moving beyond surveys to assess patient preferences.
    J Am Acad Dermatol. 2018;79:220.
    PubMed     Text format    

  10. KLAPPERICH ME, Bowen GM, Grossman D
    Current controversies in early-stage melanoma: Questions on management and surveillance.
    J Am Acad Dermatol. 2019;80:15-25.
    PubMed     Text format     Abstract available

    J Cell Physiol

  11. ZHANG P, Zhang M, Yu D, Liu W, et al
    Lycorine inhibits melanoma cell migration and metastasis mainly through reducing intracellular levels of beta-catenin and matrix metallopeptidase 9.
    J Cell Physiol. 2018 Nov 22. doi: 10.1002/jcp.27732.
    PubMed     Text format     Abstract available

  12. FANIPAKDEL A, Seilanian Toussi M, Rezazadeh F, Mohamadian Roshan N, et al
    Overexpression of cancer-testis antigen melanoma-associated antigen A1 in lung cancer: A novel biomarker for prognosis, and a possible target for immunotherapy.
    J Cell Physiol. 2018 Dec 19. doi: 10.1002/jcp.27884.
    PubMed     Text format     Abstract available

  13. CHEN M, Myers AK, Markey MP, Long W, et al
    The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness.
    J Cell Physiol. 2018 Dec 19. doi: 10.1002/jcp.27994.
    PubMed     Text format     Abstract available

    J Invest Dermatol

  14. MILES JA, Orlow I, Kanetsky PA, Luo L, et al
    Relationship of Chromosome Arm 10q Variants to Occurrence of Multiple Primary Melanoma in the Population-Based GEM Study.
    J Invest Dermatol. 2018 Dec 17. pii: S0022-202X(18)32938.
    PubMed     Text format    

    Melanoma Res

  15. DIMITRIOU F, Mangana J, Micaletto S, Braun RP, et al
    Cytokine release syndrome as an important differential diagnosis of severe skin toxicity with organ damage during switch from immunotherapy to targeted therapy in metastatic melanoma.
    Melanoma Res. 2019;29:107-108.
    PubMed     Text format    

  16. BOURSI B, Werner TJ, Gholami S, Margalit O, et al
    Physiologic colonic fluorine-18-fluorodeoxyglucose uptake may predict response to immunotherapy in patients with metastatic melanoma.
    Melanoma Res. 2018 Dec 14. doi: 10.1097/CMR.0000000000000566.
    PubMed     Text format     Abstract available

  17. CRINCOLI E, Moliterni E, Catania F, Didona D, et al
    Correlation of serum tryptase levels with total number of nevi, Breslow thickness, ulceration, and mitotic index in melanoma patients: evaluation of a promising prognostic marker.
    Melanoma Res. 2018 Dec 15. doi: 10.1097/CMR.0000000000000561.
    PubMed     Text format     Abstract available

    Nat Med

  18. TRUCCO LD, Mundra PA, Hogan K, Garcia-Martinez P, et al
    Publisher Correction: Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma.
    Nat Med. 2018 Dec 18. pii: 10.1038/s41591-018-0325.
    PubMed     Text format     Abstract available

    Oncol Rep

  19. KAWALA RA, Ramadhani FJ, Choi HJ, Lee EH, et al
    Kenalog modified by ionizing radiation induces intrinsic apoptosis mediated by elevated levels of reactive oxygen species in melanoma cancer.
    Oncol Rep. 2018 Dec 19. doi: 10.3892/or.2018.6940.
    PubMed     Text format     Abstract available

    PLoS One

  20. KITANAKA N, Nakano R, Kitanaka T, Namba S, et al
    NF-kappaB p65 and p105 implicate in interleukin 1beta-mediated COX-2 expression in melanoma cells.
    PLoS One. 2018;13:e0208955.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.